Literature DB >> 9400602

Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling.

J K Young1, R P Hicks, G E Wright, T G Morrison.   

Abstract

To investigate the molecular mechanisms involved in paramyxovirus-induced cell fusion, the function and structure of a peptide with a 20-amino-acid sequence from the leucine zipper region (heptad repeat region 2) of the Newcastle disease virus fusion protein (F) were characterized. A peptide with the sequence ALDKLEESNSKLDKVNVKLT (amino acids 478-497 of the F protein) was found to inhibit syncytia formation after virus infection and after transfection of Cos cells with the HN (hemagglutinin-neuraminidase) and F protein cDNAs. Using an F protein gene that requires addition of exogenous trypsin for cleavage, it was shown that the peptide exerted its inhibitory effect prior to cleavage. The three-dimensional conformation of the peptide in aqueous solution was determined through the use of NMR and molecular modeling. Results showed that the peptide formed a helix with properties between an alpha-helix and a 3(10)-helix and that leucine residues aligned along one face of the helix. Side chain salt bridges and hydrogen bonds likely contributed to the stability of the peptide secondary structure. Analysis of the aqueous solution conformation of the peptide suggested mechanisms for specificity of interaction with the intact F protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9400602     DOI: 10.1006/viro.1997.8834

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  40 in total

1.  The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.

Authors:  J M Matthews; T F Young; S P Tucker; J P Mackay
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Mutations in the fusion peptide and adjacent heptad repeat inhibit folding or activity of the Newcastle disease virus fusion protein.

Authors:  T A Sergel; L W McGinnes; T G Morrison
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

3.  Inhibition of hendra virus fusion.

Authors:  M Porotto; L Doctor; P Carta; M Fornabaio; O Greengard; G E Kellogg; A Moscona
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  A small-molecule dengue virus entry inhibitor.

Authors:  Qing-Yin Wang; Sejal J Patel; Eric Vangrevelinghe; Hao Ying Xu; Ranga Rao; Deana Jaber; Wouter Schul; Feng Gu; Olivier Heudi; Ngai Ling Ma; Mee Kian Poh; Wai Yee Phong; Thomas H Keller; Edgar Jacoby; Subhash G Vasudevan
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

5.  Kinetic dependence of paramyxovirus entry inhibition.

Authors:  Matteo Porotto; Christine C Yokoyama; Gianmarco Orefice; Han-Sung Kim; Mohamed Aljofan; Bruce A Mungall; Anne Moscona
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

6.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

Review 7.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

8.  Viral entry inhibitors targeted to the membrane site of action.

Authors:  Matteo Porotto; Christine C Yokoyama; Laura M Palermo; Bruce Mungall; Mohamad Aljofan; Riccardo Cortese; Antonello Pessi; Anne Moscona
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

9.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.